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O
ver the past century, the plant kingdom as well as
the marine and microbial worlds have provided sci-
entists with a plethora of small molecules. With
their unique and diverse structural scaffolds, these
natural products have inspired chemists, biochem-
ists, biologists, and microbiologists alike and not only pro-
vided the mankind with life-saving antimicrobials, but also
contributed to the development of new chemical and bio-
chemical tools. The broad range of biological properties has
also kept Nature’s small molecules at the core of the drug dis-
covery process.1 With many more natural products to be dis-
covered,2 chemically or chemoenzymatically modified, or ge-
netically engineered,3 this remains an active area of research.
In these exciting times where the ever expanding genomic in-
formation,4 high-throughput and bioinformatics5,6 capabil-
ities, mass spectrometry, X-ray crystallography, and NMR are
widely accessible and getting more and more sophisticated,
one can easily envision a variety of novel directions for future
natural product research.
In this Special Series, experts in the fields of natural
product synthesis, biosynthesis, isolation, identification,
and production, provide the latest updates and discoveries
in the study of natural products. These molecules can be di-
vided into two classes: (i) the non-templated natural prod-
ucts that include alkaloids,7–9 oligosaccharides,10 and ami-
noglycosides11 and (ii) the templated natural products that
comprise the fatty acids (FAs),12 polyketides (PKs),13,14 and
nonribosomal peptides (NRPs).15,16 In this issue, a special
attention is given to molecules that belong to the latter
class. The fascinating modular biosynthetic logic utilized by
fatty acid synthase (FAS), polyketide synthase (PKS), and
nonribosomal peptide synthetase (NRPS) enzymes for the
production of these structurally unique and diverse mole-
cules has been and continues to be the focus of many
research programs. Despite decades of extensive investiga-
tions directed towards the understanding of these complex
machineries, multiple questions remain to be answered.
Only recently, thanks to the power of X-ray crystallography,
a clearer molecular picture of how these multi-enzyme
complexes function has emerged.17 In the years to come, it
is predicted that a new trend in merging scientific disci-
plines related to natural product research will enable the de-
velopment of new chemical, biochemical, and genetic tools
as well as the discovery of novel natural products and ana-
logs with potential therapeutic applications.
While navigating this Special Series, the reader should
keep in mind the following questions: (i) where do natural
products come from? (ii) what new tools are currently being
developed for their study? (iii) how can one use what has
been learnt to produce novel analogs of these compounds as
potential therapeutics? and finally (iv) what is the future
role of natural products in drug development and discov-
ery? There are most definitely multiple good answers to
these questions, and many more questions can come to
mind.
In parallel to the extraordinary diversity of publications in
the field of natural products, the manuscripts in this Special
Series are intended to provide an overview of the latest and
future trends in this ever-growing area of research. This issue
of Biopolymers features three review articles that highlight
the recent advances in our understanding of three different
classes of polyketide and nonribosomal peptide natural prod-
ucts. Campbell and Vederas provide a thorough overview of
the biosynthesis of the cholesterol lowering agent lovastatin
and its related metabolites, whereas Du and his colleagues
contribute an in-depth analysis of the polyketide-derived
mycotoxins. Together, these reviews elegantly summarize the
current knowledge associated with fungal iterative PKS
enzymes. Garneau-Tsodikova and coworkers introduce us to
the world of nonribosomal peptides with a comprehensive
discussion on bisintercalator natural products, their biosyn-
thesis, the novel strategies for the production of their ana-
logs, and insight into bacterial resistance. This Special Series
also features five research articles describing some of the lat-
est discoveries in the field. Moon and Van Lanen present the
exciting characterization of a unique adenylation enzyme
with dual specificity and dual function involved in the bio-
synthesis of the dipeptide antifungal antibiotic nikkomycin.
With their study of the tyrosine aminomutase SgTAM, Cooke
and Bruner nicely demonstrate how a combination of
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biochemical and structural studies can provide useful
insights into the mechanism of action of enzymes. Following
a conceptually similar approach, Campopiano and coworkers
with their study of the serine palmitoyltransferase from
Sphingomonas wittichii RW1 propose an interesting link
between fatty acid and sphingolipid metabolism. Finally, two
fascinating and insightful manuscripts by Heide and co-
workers and Brady and coworkers describing novel method-
ologies for heterologous production of natural products
demonstrate the future directions in the study of these
molecules.
Overall, beyond the specific and complementary findings
presented in the individual articles of this Special Series, we
hope that other experts working on natural products will be
inspired by these studies, and that readers that are new to the
field will be encouraged to learn more about it and maybe
even find their own niche of research in this amazing and
continuously evolving resource of compounds that Nature
provides us with.
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